Paula Cannon, Ph.D. is a Distinguished Professor in the Keck School of Medicine of the University of Southern California in Los Angeles. She studies genome engineering in hematopoietic stem cells, with an emphasis on developing therapies for HIV/AIDS. Dr. Cannon earned her Ph.D. from the University of Liverpool and did post-doctoral training at Harvard and Oxford Universities. In 2010, her team were the first to show that genome engineering could be used to knock-out the CCR5 gene in human hematopoietic stem cells, which has now led to an ongoing clinical trial in HIV-infected individuals. She continues to develop new applications for genome engineering, with a goal of applying this technology to treat infectious and genetic diseases of the blood and immune systems.
« Go Back